SpaceX Plans Starship Program For In-Orbit Drug Research- Bloomberg News

ReutersJul 15, 2025 2:31 PM

View all comments（0）



July 15 (Reuters) -

SPACEX PLANS STARSHIP PROGRAM FOR IN-ORBIT DRUG RESEARCH- BLOOMBERG NEWS
SPACEX PLANS TO MAKE STARSHIP PROGRAM FOR IN-ORBIT DRUG RESEARCH OPERATIONAL ROUGHLY BY THE END OF THE DECADE- BLOOMBERG NEWS

Source text: https://bloom.bg/4lxaW5T

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Today’s Market Recap: Tech-Led Rally Drives Record Highs as Trump Arrives in Beijing

Tech-driven gains pushed the S&P 500 and Nasdaq to record highs as President Trump arrived in Beijing alongside Nvidia's CEO. Despite surging PPI data fueling rate-hike fears, strong AI-related growth from Cisco and Alibaba, plus Cerebras Systems' massive IPO demand, sustained investor optimism acro

SKC Invests 1.17 Trillion Won in Glass Substrates, Can It Help SK Hynix Further Widen the Gap With Samsung?

TradingKey - SKC, a materials unit of South Korea’s SK Group, recently announced plans to raise 1.17 trillion KRW through a rights issue. Approximately 589.6 billion KRW will be allocated to its U.S. subsidiary, Absolix, for glass substrate mass production plans over the next three years. This marks

Anthropic in Talks for Massive $30 Billion Funding, Valuation May Join Trillion-Dollar Ranks

TradingKey - On May 12, Eastern Time, Bloomberg reported that AI startup Anthropic is in preliminary discussions with investors to raise at least $30 billion in new capital at a pre-money valuation exceeding $900 billion. If the deal is finalized, it would mark the company's largest funding round to

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools